SPDR S&P Biotech ETF (XBI)
88.94
2.28 (2.63%)
At close: Jan 15, 2025, 10:30 AM
undefined% (undefined)
| Bid | 88.97 |
| Market Cap | 6.35B |
| AUM | - |
| NAV | - |
| EPS (ttm) | 0.00 |
| PE Ratio (ttm) | n/a |
| Shares Out | 71.45M |
| Inception Date | Invalid Date |
| Ask | 88.99 |
| Volume | 4.65M |
| Open | 88.70 |
| Previous Close | 86.66 |
| Day's Range | 88.18 - 89.60 |
| 52-Week Range | 81.14 - 105.47 |
| Holdings | - |
| Expense Ratio | undefined% |
About XBI
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Asset Class Equity
Ticker Symbol XBI
Inception Date Jan 31, 2006
Provider State Street
Website Fund Home Page
Top Holdings 15.19% of assets
| Company | Portfolio |
|---|---|
NTRA Natera, Inc. | 3.57% |
GILD Gilead Sciences, Inc... | 2.94% |
UTHR United Therapeutics ... | 2.90% |
INCY Incyte Corporation | 2.90% |
NBIX Neurocrine Bioscienc... | 2.88% |
Dividends Dividend Yield 0.01%
| Ex-Dividend | Payment Date | Amount |
|---|---|---|
| Dec 23, 2024 | Dec 26, 2024 | $0.00 |
| Sep 23, 2024 | Sep 25, 2024 | $0.02 |
| Jun 24, 2024 | Jun 26, 2024 | $0.11 |
| Dec 18, 2023 | Dec 21, 2023 | $0.01 |
| Jun 20, 2023 | Jun 23, 2023 | $0.00 |
